Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
Clinical trial NCT03839342 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03839342
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-07
- Primary completion
- 2026-12-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.